Table 1.

Outcomes of the current systematic review.

	Categories of Outcomes	Outcomes Included
Primary outcomes	Mortality	All-cause mortality; BC mortality; non-BC mortality.
	BC recurrence and/or newly diagnosed cancer progression	e.g., local recurrence; metastasis.
	Quality of life	Measured by generic or cancer-specific validated scales, (e.g., Functional Assessment of Cancer Therapy—Breast Cancer).
Secondary outcomes	Health-related parameters	Biochemical parameters, (e.g., blood glucose and blood lipids, including total cholesterol, low-density lipoproteins, high-density lipoproteins, triglycerides).
		Anthropometric measurements, (e.g., body-mass index, waist circumference, body weight).
	Incidence of long-term/late-effect BC treatments	Osteoporosis/osteopenia/fracture; obesity/cardiovascular disease/stroke/diabetes; endometrial cancer/other secondary cancer (primary cancer); cognitive impairment; mortality from cancer treatments.
	Adverse events

BC: breast cancer.